학술논문

Clinical value of cancer-associated myositis-specific antibodies, anti-transcriptional intermediary factor 1-γ, and anti-nuclear matrix protein 2 antibodies in a retrospective cohort of dermatomyositis/polymyositis in a Japanese community hospital
Document Type
Article
Source
In: Clinical Rheumatology. (Clinical Rheumatology, September 2022, 41(9):2803-2808)
Subject
Language
English
ISSN
14349949
07703198